We observed a poorer prognosis in patients with top 20% ITGA4 expression compared to those with the bottom 20% (Figure 9A), correlating with findings from pan-cancer studies linking higher ITGA4 expression to advanced GC stages and grades. The gene discussed is ITGA4; the disease is cancer.